About Me
Dr. Danielle Dubin is a board certified dermatologist specializing in both general and cosmetic dermatology, with a particular expertise in treating disorders of pigmentation, including melasma, post-inflammatory hyperpigmentation, and photodamage at the Kimberly and Eric J. Waldman Department of Dermatology at Mount Sinai. She is dedicated to providing comprehensive care for her patients, addressing both medical and aesthetic skin concerns.
Dr. Dubin earned her medical degree from Albert Einstein College of Medicine, where she graduated with honors as a member of Alpha Omega Alpha. She went on to complete her dermatology residency at Mount Sinai, where she served as Chief Resident in her final year of training.
Throughout her career, Dr. Dubin has been an active contributor to dermatological research, with numerous PubMed publications covering topics such as drug rashes, skin cancer, and advances in cosmetic dermatology. Her passion for dermatology lies in combining her scientific expertise with personalized patient care, offering the most advanced and effective treatments to meet her patients' needs.
Language
English
Position
ASSISTANT PROFESSOR | Dermatology
Clinical Focus
- Acne
- Aging
- Atopic Dermatitis
- Cosmetic Consultation
- Hyperhidrosis
- Hyperpigmentation
- Melasma
- Pigmentary Disorders
- Psoriasis Vulgaris
- Rosacea
- Scars
- Seborrheic Dermatitis
- Sun Damage
- Vascular Lesions
- Wrinkles
Education
MD, Albert Einstein College of Medicine
Awards
2020
New award
Alpha Omega Alpha Honor Medical Society
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Dubin has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.